Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-02-13

FDA Approved: HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE — Original Application (Novel Laboratories, Inc.)

View source ↗

Summary

FDA approved Novel Laboratories, Inc.'s generic hydrocodone bitartrate and homatropine methylbromide tablets (Original Application) for cough suppression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydrocodone Bitartrate and Homatropine Methylbromide (Hydrocodone Bitartrate and Homatropine Methylbromide)

Snippet

ORIG AP for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE (HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE)